Interactions of Ly333531 and Other Bisindolyl Maleimide Inhibitors with Pdk1
Komander, D., Kular, G.S., Schuttelkopf, A.W., Deak, M., Prakash, K.R., Bain, J., Elliot, M., Garrido-Franco, M., Kozikowski, A.P., Alessi, D.R., Van Aalten, D.M.F.(2004) Structure 12: 215
- PubMed: 14962382 
- DOI: 10.1016/j.str.2004.01.005
- Primary Citation of Related Structures:  
1UVR, 1UU8, 1UU7, 1UU3, 1UU9 - PubMed Abstract: 
LY333531, BIM-1, BIM-2, BIM-3, and BIM-8 are bisindolyl maleimide-based, nanomolar protein kinase C inhibitors. LY333531, a PKCbeta-specific inhibitor, is in clinical trials against diabetes and cardiac ventricular hypertrophy complications. Specific ...